000230260 000__ 01368cam\a2200337Ia\45e0
000230260 001__ 230260
000230260 005__ 20220217104315.0
000230260 008__ 000225s2000\\\\dcua\\\\\b\\\f000\0\eng\d
000230260 020__ $$a0160600324
000230260 035__ $$a(OCoLC)ocm43523640
000230260 035__ $$a230260
000230260 040__ $$aFTC$$cFTC$$dGPO
000230260 043__ $$an-us---
000230260 049__ $$aISEA
000230260 074__ $$a1016-A
000230260 074__ $$a1016-B (MF)
000230260 0860_ $$aY 4.G 74/7:F 31/86
000230260 088__ $$aSerial no. 106-60 (United States. Congress. House. Committee on Government Reform)
000230260 090__ $$aTX553.A3$$bU5H 1999
000230260 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Government Reform.
000230260 24510 $$aHow accurate is the FDA's monitoring of supplements like ephedra? :$$bhearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999.
000230260 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c2000.
000230260 300__ $$aiii, 214 p. :$$bill. ;$$c24 cm.
000230260 500__ $$aDistributed to some depository libraries in microfiche.
000230260 500__ $$aShipping list no.: 2000-0137-P.
000230260 500__ $$a"Serial no. 106-60."
000230260 504__ $$aIncludes bibliographical references.
000230260 61010 $$aUnited States.$$bFood and Drug Administration.
000230260 650_0 $$aDietary supplements$$zUnited States.
000230260 650_0 $$aEphedra$$zUnited States.
000230260 85230 $$bdfich$$hY 4.G 74/7:$$iF 31/86
000230260 909CO $$ooai:library.usi.edu:230260$$pGLOBAL_SET
000230260 980__ $$aBIB
000230260 980__ $$aGOV RESOURCE
000230260 994__ $$aE0$$bISE